ID   TYW5_HUMAN              Reviewed;         315 AA.
AC   A2RUC4; B2RNE3; Q8N1R2;
DT   13-NOV-2007, integrated into UniProtKB/Swiss-Prot.
DT   06-MAR-2007, sequence version 1.
DT   07-JAN-2015, entry version 70.
DE   RecName: Full=tRNA wybutosine-synthesizing protein 5;
DE            Short=hTYW5;
DE            EC=1.14.11.42;
DE   AltName: Full=tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-C(2))-hydroxylase;
GN   Name=TYW5; Synonyms=C2orf60;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Retinoblastoma;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, AND PATHWAY.
RX   PubMed=20739293; DOI=10.1074/jbc.M110.156398;
RA   Noma A., Ishitani R., Kato M., Nagao A., Nureki O., Suzuki T.;
RT   "Expanding role of the jumonji C domain as an RNA hydroxylase.";
RL   J. Biol. Chem. 285:34503-34507(2010).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 4-311 IN COMPLEX WITH
RP   2-OXOGLUTARATE AND NICKEL ION, PATHWAY, COFACTOR, SUBUNIT, AND
RP   MUTAGENESIS OF ARG-108 AND ARG-149.
RX   PubMed=20972222; DOI=10.1093/nar/gkq919;
RA   Kato M., Araiso Y., Noma A., Nagao A., Suzuki T., Ishitani R.,
RA   Nureki O.;
RT   "Crystal structure of a novel JmjC-domain-containing protein, TYW5,
RT   involved in tRNA modification.";
RL   Nucleic Acids Res. 39:1576-1585(2011).
CC   -!- FUNCTION: tRNA hydroxylase that acts as a component of the
CC       wybutosine biosynthesis pathway. Wybutosine is a hyper modified
CC       guanosine with a tricyclic base found at the 3'-position adjacent
CC       to the anticodon of eukaryotic phenylalanine tRNA. Catalyzes the
CC       hydroxylation of 7-(a-amino-a-carboxypropyl)wyosine (yW-72) into
CC       undermodified hydroxywybutosine (OHyW*). OHyW* being further
CC       transformed into hydroxywybutosine (OHyW) by LCMT2/TYW4. OHyW is a
CC       derivative of wybutosine found in higher eukaryotes.
CC       {ECO:0000269|PubMed:20739293}.
CC   -!- CATALYTIC ACTIVITY: 7-(3-amino-3-carboxypropyl)wyosine(37) in
CC       tRNA(Phe) + 2-oxoglutarate + O(2) = 7-(2-hydroxy-3-amino-3-
CC       carboxypropyl)wyosine(37) in tRNA(Phe) + succinate + CO(2).
CC   -!- COFACTOR:
CC       Name=Fe(2+); Xref=ChEBI:CHEBI:29033;
CC         Evidence={ECO:0000269|PubMed:20972222};
CC       Note=Binds 1 Fe(2+) ion per subunit.
CC       {ECO:0000269|PubMed:20972222};
CC   -!- PATHWAY: tRNA modification; wybutosine-tRNA(Phe) biosynthesis.
CC       {ECO:0000269|PubMed:20739293, ECO:0000269|PubMed:20972222}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:20972222}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=A2RUC4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=A2RUC4-2; Sequence=VSP_029106;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the TYW5 family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 JmjC domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00538}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH63502.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK095272; BAC04517.1; -; mRNA.
DR   EMBL; AK298977; BAG61071.1; -; mRNA.
DR   EMBL; AC097717; AAY24162.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70191.1; -; Genomic_DNA.
DR   EMBL; BC063502; AAH63502.1; ALT_INIT; mRNA.
DR   EMBL; BC132835; AAI32836.1; -; mRNA.
DR   EMBL; BC136837; AAI36838.1; -; mRNA.
DR   CCDS; CCDS42795.1; -. [A2RUC4-1]
DR   RefSeq; NP_001034782.1; NM_001039693.2. [A2RUC4-1]
DR   UniGene; Hs.204619; -.
DR   PDB; 3AL5; X-ray; 2.50 A; A/B/C/D=1-315.
DR   PDB; 3AL6; X-ray; 2.80 A; A/B/C/D=1-315.
DR   PDBsum; 3AL5; -.
DR   PDBsum; 3AL6; -.
DR   ProteinModelPortal; A2RUC4; -.
DR   SMR; A2RUC4; 1-311.
DR   BioGrid; 126193; 10.
DR   STRING; 9606.ENSP00000346627; -.
DR   PhosphoSite; A2RUC4; -.
DR   MaxQB; A2RUC4; -.
DR   PaxDb; A2RUC4; -.
DR   PRIDE; A2RUC4; -.
DR   DNASU; 129450; -.
DR   Ensembl; ENST00000354611; ENSP00000346627; ENSG00000162971. [A2RUC4-1]
DR   GeneID; 129450; -.
DR   KEGG; hsa:129450; -.
DR   UCSC; uc002uvi.4; human. [A2RUC4-1]
DR   UCSC; uc002uvj.4; human. [A2RUC4-2]
DR   CTD; 129450; -.
DR   GeneCards; GC02M200794; -.
DR   H-InvDB; HIX0002719; -.
DR   HGNC; HGNC:26754; TYW5.
DR   HPA; HPA045803; -.
DR   neXtProt; NX_A2RUC4; -.
DR   PharmGKB; PA162379298; -.
DR   eggNOG; NOG276154; -.
DR   GeneTree; ENSGT00530000062914; -.
DR   HOVERGEN; HBG096249; -.
DR   InParanoid; A2RUC4; -.
DR   KO; K18066; -.
DR   OMA; RMVLRIQ; -.
DR   OrthoDB; EOG7X3QRF; -.
DR   PhylomeDB; A2RUC4; -.
DR   TreeFam; TF332364; -.
DR   UniPathway; UPA00375; -.
DR   GenomeRNAi; 129450; -.
DR   NextBio; 82587; -.
DR   PRO; PR:A2RUC4; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; A2RUC4; -.
DR   CleanEx; HS_C2orf60; -.
DR   ExpressionAtlas; A2RUC4; baseline and differential.
DR   Genevestigator; A2RUC4; -.
DR   GO; GO:0005506; F:iron ion binding; IDA:UniProtKB.
DR   GO; GO:0016706; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0000049; F:tRNA binding; IDA:UniProtKB.
DR   GO; GO:0031591; P:wybutosine biosynthetic process; IDA:UniProtKB.
DR   InterPro; IPR003347; JmjC_dom.
DR   InterPro; IPR029612; TYW5.
DR   PANTHER; PTHR12461:SF24; PTHR12461:SF24; 1.
DR   SMART; SM00558; JmjC; 1.
DR   PROSITE; PS51184; JMJC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Dioxygenase;
KW   Iron; Metal-binding; Oxidoreductase; Polymorphism; Reference proteome;
KW   tRNA processing.
FT   CHAIN         1    315       tRNA wybutosine-synthesizing protein 5.
FT                                /FTId=PRO_0000309274.
FT   DOMAIN      102    267       JmjC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00538}.
FT   METAL       160    160       Iron; catalytic.
FT   METAL       162    162       Iron; catalytic.
FT   METAL       235    235       Iron; catalytic.
FT   BINDING     106    106       2-oxoglutarate.
FT                                {ECO:0000269|PubMed:20972222}.
FT   BINDING     166    166       2-oxoglutarate.
FT                                {ECO:0000269|PubMed:20972222}.
FT   BINDING     175    175       2-oxoglutarate.
FT                                {ECO:0000269|PubMed:20972222}.
FT   VAR_SEQ       1    163       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_029106.
FT   VARIANT      50     50       S -> G (in dbSNP:rs10497844).
FT                                /FTId=VAR_036926.
FT   MUTAGEN     108    108       R->A: Abolishes enzyme activity and
FT                                ability to bind tRNA.
FT                                {ECO:0000269|PubMed:20972222}.
FT   MUTAGEN     149    149       R->A: Abolishes enzyme activity and
FT                                ability to bind tRNA.
FT                                {ECO:0000269|PubMed:20972222}.
FT   STRAND       10     13       {ECO:0000244|PDB:3AL5}.
FT   HELIX        16     22       {ECO:0000244|PDB:3AL5}.
FT   HELIX        24     26       {ECO:0000244|PDB:3AL5}.
FT   STRAND       30     34       {ECO:0000244|PDB:3AL5}.
FT   HELIX        40     43       {ECO:0000244|PDB:3AL5}.
FT   HELIX        46     53       {ECO:0000244|PDB:3AL5}.
FT   STRAND       57     62       {ECO:0000244|PDB:3AL5}.
FT   STRAND       76     81       {ECO:0000244|PDB:3AL5}.
FT   HELIX        82     90       {ECO:0000244|PDB:3AL5}.
FT   STRAND      106    108       {ECO:0000244|PDB:3AL5}.
FT   TURN        114    116       {ECO:0000244|PDB:3AL5}.
FT   HELIX       121    124       {ECO:0000244|PDB:3AL5}.
FT   HELIX       126    129       {ECO:0000244|PDB:3AL5}.
FT   HELIX       140    142       {ECO:0000244|PDB:3AL5}.
FT   STRAND      143    151       {ECO:0000244|PDB:3AL5}.
FT   STRAND      156    160       {ECO:0000244|PDB:3AL5}.
FT   STRAND      163    170       {ECO:0000244|PDB:3AL5}.
FT   STRAND      175    180       {ECO:0000244|PDB:3AL5}.
FT   HELIX       182    188       {ECO:0000244|PDB:3AL5}.
FT   STRAND      194    196       {ECO:0000244|PDB:3AL5}.
FT   STRAND      200    202       {ECO:0000244|PDB:3AL5}.
FT   TURN        205    207       {ECO:0000244|PDB:3AL5}.
FT   HELIX       211    213       {ECO:0000244|PDB:3AL5}.
FT   STRAND      216    221       {ECO:0000244|PDB:3AL5}.
FT   STRAND      226    229       {ECO:0000244|PDB:3AL5}.
FT   STRAND      234    241       {ECO:0000244|PDB:3AL5}.
FT   STRAND      243    250       {ECO:0000244|PDB:3AL5}.
FT   HELIX       255    257       {ECO:0000244|PDB:3AL5}.
FT   STRAND      263    265       {ECO:0000244|PDB:3AL5}.
FT   HELIX       270    286       {ECO:0000244|PDB:3AL5}.
FT   HELIX       291    308       {ECO:0000244|PDB:3AL5}.
SQ   SEQUENCE   315 AA;  36548 MW;  F291C48E8CA729FE CRC64;
     MAGQHLPVPR LEGVSREQFM QHLYPQRKPL VLEGIDLGPC TSKWTVDYLS QVGGKKEVKI
     HVAAVAQMDF ISKNFVYRTL PFDQLVQRAA EEKHKEFFVS EDEKYYLRSL GEDPRKDVAD
     IRKQFPLLKG DIKFPEFFKE EQFFSSVFRI SSPGLQLWTH YDVMDNLLIQ VTGKKRVVLF
     SPRDAQYLYL KGTKSEVLNI DNPDLAKYPL FSKARRYECS LEAGDVLFIP ALWFHNVISE
     EFGVGVNIFW KHLPSECYDK TDTYGNKDPT AASRAAQILD RALKTLAELP EEYRDFYARR
     MVLHIQDKAY SKNSE
//
